

Episode 4463: Trump Bans Gain Of Function Research
May 5, 2025
Naomi Wolf, an author and journalist known for her critical insights on women's health, joins political analyst Jane Zirkle to dive into pressing issues. They discuss the recent ban on gain-of-function research and its risks, particularly in light of the COVID-19 pandemic. The conversation shifts to criminal justice reform, focusing on urgent needs within the Fulton County Jail, and explores public distrust in health policies, especially regarding mRNA vaccines and women's fertility. The episode is a blend of serious discourse and engaging insights.
AI Snips
Chapters
Transcript
Episode notes
No Benefit from Gain of Function Research
- There has been no beneficial outcome from gain of function research historically.
- Ending U.S. gain of function research reduces pandemic risks from accidental leaks.
Pharmaceutical Self-Sufficiency Priority
- Reliance on overseas pharmaceutical production causes shortages in crucial medicines.
- Trump's executive order promotes bringing drug manufacturing back to the U.S. for self-sufficiency.
Drug Supply Chain Vulnerability
- Active pharmaceutical ingredients are 100% controlled by China.
- The executive order aims to repatriate critical drug ingredient manufacturing to America.